Skip to main content

Table 2 Univariate analysis of differentiation syndrome in patients with acute promyelocytic leukemia

From: Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia

Clinical characteristics

Patients without DS(n = 32cases)

Patients with DS(n = 53 cases)

Statistical value (χor Z value)

P-value

WBC count at diagnosis (× 109/L)

1.77(0.19 ~ 192.63)

4.92(0.46 ~ 108.75)

1.968

0.049

WBC count at diagnosis≥3 × 109/L

26.1%(12/46)

73.9%(34/46)

5.708

0.017

WBC count at diagnosis< 3 × 109/L

51.3%(20/39)

48.7%(19/39)

Percentage of monocytes at diagnosis (%)

23.15(2.3 ~ 88.4)

41.8(0.9 ~ 85.9)

2.037

0.042

WBC on Day 5

 WBC count on Day 5 ≥ 10 × 109/L

20.5%(8/39)

79.5%(31/39)

5.341

0.021

 WBC count on Day 5 < 10 × 109/L

46.7%(14/30)

53.3%(16/30)

Peak WBC (×109/L)

18.26(1.56 ~ 194.43)

32.70(4.35 ~ 112.85)

−2.807

0.005

Peak WBC count ≥16 × 109/L

22.2%(12/54)

77.8%(42/54)

12.112

0.001

Peak WBC count < 16 × 109/L

68.8%(11/16)

31.3%(5/16)

Percentage of bone marrow promyelocytes (%)

77.5(5.0 ~ 96.5)

85.0(26.0 ~ 95.5)

−2.039

0.041

Time for bone marrow to achieve remission(day)

22(17 ~ 35)

26(17 ~ 41)

−1.835

0.067

Transfusion of RBC (U)

5.0(0 ~ 15)

8.0(0 ~ 22)

−3.277

0.001

Transfusion of PLT (therapeutic volumes)

1(0 ~ 6)

2(0 ~ 12)

−3.769

0.000

  1. DS differentiation syndrome, WBC white blood cells, RBC red blood cells, PLT platelets